Related Experiment Video
Updated: Aug 11, 2026
07:45
A Cell Free Assay System Estimating the Neutralizing Capacity of GM-CSF Antibody using Recombinant Soluble GM-CSF Receptor
Published on: June 27, 2011
Monomeric and dimeric forms of soluble receptors can differ in their neutralization potential
Behring Institute Mitteilungen
|June 1, 1995
Summary
Recombinant soluble receptors can be monomeric or dimeric. Dimeric receptors bind trimeric ligands, like tumor necrosis factor family members, with higher affinity than monomeric receptors, impacting neutralization potential.
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- Recombinant soluble receptors are crucial tools in biological research and therapeutics.
- Transmembrane receptors exist in various quaternary structures, influencing their interactions.
- Understanding receptor-ligand interactions is key to developing effective treatments.
Purpose of the Study:
- To investigate how the quaternary structure of soluble receptors (monomeric vs. dimeric) affects their binding affinity and neutralization potential.
- To determine the influence of ligand quaternary structure on receptor binding dynamics.
Main Methods:
- Production of recombinant soluble receptor variants (monomeric and dimeric).
- Characterization of binding affinities using various ligand forms (monomeric and trimeric).
- Assessment of neutralization potential based on binding data.
Main Results:
- Both monomeric and dimeric soluble receptors bind monomeric ligands with similar affinity.
- Dimeric soluble receptors exhibit significantly higher binding affinity for trimeric ligands compared to monomeric receptors.
- This differential binding suggests varying neutralization capacities based on receptor and ligand structure.
Conclusions:
- The quaternary structure of soluble receptors critically modulates their interaction with ligands.
- Dimeric soluble receptors are more effective in binding and potentially neutralizing multimeric ligands, such as tumor necrosis factor superfamily members.
- These findings have implications for the design and application of soluble receptor-based therapies.
Related Concept Videos
02:40Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
01:58Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
01:29Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
01:25Dose-Response Relationship: Selectivity and Specificity
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...
01:29The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...
01:25Antibody Structure and Classes
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.